Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 48 studies | 59% ± 20% | |
endothelial cell of artery | 16 studies | 65% ± 17% | |
vein endothelial cell | 16 studies | 78% ± 19% | |
capillary endothelial cell | 15 studies | 56% ± 18% | |
endothelial cell of lymphatic vessel | 14 studies | 31% ± 12% | |
endothelial cell of vascular tree | 13 studies | 59% ± 18% | |
pericyte | 4 studies | 64% ± 20% | |
endothelial cell of sinusoid | 3 studies | 41% ± 22% | |
endocardial cell | 3 studies | 49% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 4 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 55115.97 | 459 / 459 | 95% | 63.04 | 1066 / 1118 |
thymus | 99% | 25607.01 | 646 / 653 | 95% | 77.17 | 575 / 605 |
lung | 100% | 51011.23 | 577 / 578 | 89% | 54.76 | 1029 / 1155 |
esophagus | 93% | 16982.82 | 1348 / 1445 | 91% | 60.59 | 166 / 183 |
bladder | 100% | 17775.38 | 21 / 21 | 83% | 35.56 | 418 / 504 |
uterus | 99% | 27363.73 | 169 / 170 | 81% | 36.25 | 372 / 459 |
prostate | 86% | 13119.91 | 211 / 245 | 94% | 50.35 | 473 / 502 |
intestine | 94% | 15285.51 | 911 / 966 | 82% | 39.19 | 431 / 527 |
stomach | 77% | 9207.25 | 277 / 359 | 85% | 46.66 | 242 / 286 |
skin | 54% | 6394.12 | 974 / 1809 | 81% | 38.06 | 382 / 472 |
ovary | 71% | 9391.43 | 127 / 180 | 62% | 19.35 | 265 / 430 |
brain | 36% | 3241.58 | 947 / 2642 | 92% | 51.98 | 651 / 705 |
pancreas | 25% | 1818.15 | 82 / 328 | 97% | 57.33 | 173 / 178 |
kidney | 30% | 3262.58 | 27 / 89 | 91% | 255.34 | 818 / 901 |
adrenal gland | 12% | 964.90 | 32 / 258 | 90% | 95.36 | 208 / 230 |
adipose | 100% | 70184.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 32865.93 | 852 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 40.05 | 28 / 29 |
spleen | 96% | 20797.52 | 231 / 241 | 0% | 0 | 0 / 0 |
muscle | 91% | 11120.06 | 727 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 39.72 | 40 / 45 |
blood vessel | 85% | 15680.57 | 1131 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 28.37 | 65 / 80 |
liver | 1% | 58.63 | 2 / 226 | 57% | 19.01 | 230 / 406 |
peripheral blood | 1% | 56.36 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_1902533 | Biological process | positive regulation of intracellular signal transduction |
GO_0007155 | Biological process | cell adhesion |
GO_0007596 | Biological process | blood coagulation |
GO_0030168 | Biological process | platelet activation |
GO_0007599 | Biological process | hemostasis |
GO_0009611 | Biological process | response to wounding |
GO_0005615 | Cellular component | extracellular space |
GO_0031091 | Cellular component | platelet alpha granule |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0033093 | Cellular component | Weibel-Palade body |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0019865 | Molecular function | immunoglobulin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005178 | Molecular function | integrin binding |
GO_0002020 | Molecular function | protease binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0005518 | Molecular function | collagen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VWF |
Protein name | von Willebrand factor (vWF) [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II)] von Willebrand factor (vWF) von Willebrand factor |
Synonyms | F8VWF |
Description | FUNCTION: Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. FUNCTION: Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. . |
Accessions | A0A858XAB0 ENST00000261405.10 [P04275-1] P04275 H2DLA2 L8E853 ENST00000321023.5 I3L4K4 ENST00000538563.1 |